Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.

The most read First Opinion essays of 2024 covered everything from the health insurance industry backlash to the right way to ...

Overall, 2025 is likely to feature significant discourse about the future of drug policy, addiction treatment, and harm ...

The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may ...

WASHINGTON — Robert F. Kennedy Jr.’s Make American Healthy Again movement calls for many things — avoiding chronic disease, ...

Top executives at Omada, Transcarent, Hinge Health and Maven Clinic reflect on the year that passed, and the year ahead for ...

Aletha Maybank, who became the American Medical Association’s first chief equity officer five and half years ago, is leaving ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening ...

Former President Jimmy Carter, who died Sunday at age 100, gave visibility to devastating health problems that are often ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...